http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005075630-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
| filingDate | 2005-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b19e9441da08f9fcc91a2d148c9174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a815d120d18a69d36ef9c4ce44e8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b9192f647409ae2db8f2c99d6e559d |
| publicationDate | 2005-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2005075630-A2 |
| titleOfInvention | New acylglycerol acyltransferase-like proteins dc4 and uses thereof |
| abstract | The present invention is directed to polynucleotide and polypeptide sequences of novel acylglycerol acyltransferase-like proteins DC4. The invention also provides the human, mouse and rat DC4 and rat and mouse DC4L associated with the cardiovascular diseases, dermatological diseases, metabolic diseases, muscle-skeleton disorders, cancer, inflammation, urological diseases, neurological diseases and hematological diseases. The invention also provides assays for the identification of compounds useful for the modulation of cardiovascular diseases, dermatological diseases, metabolic diseases, muscle-skeleton disorders, cancer, inflammation, urological diseases, neurological diseases and hematological diseases for treating of cardiovascular diseases, dermatological diseases, metabolic diseases, muscle-skeleton disorders, cancer, inflammation, urological diseases, neurological diseases and hematological diseases associated with expression of the DC4. The invention also features compounds which bind to and/or activate or inhibit the activity of DC4 as well as pharmaceutical compositions comprising such compounds. |
| priorityDate | 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2018.